Search Results - Thorsten Schlomm

Refine Results
  1. 1
    MethylBERT enables read-level DNA methylation pattern identification and tumour deconvolution using a Transformer-based model

    MethylBERT enables read-level DNA methylation pattern identification and tumour deconvolution using a Transformer-based model by Yunhee Jeong, Clarissa Gerhäuser, Guido Sauter, Thorsten Schlomm, Karl Rohr, Pavlo Lutsik

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Circulating miRNAs are correlated with tumor progression in prostate cancer

    Circulating miRNAs are correlated with tumor progression in prostate cancer by Jan C. Brase, Marc Johannes, Thorsten Schlomm, Maria Fälth, Alexander Haese, Thomas Steuber, Tim Beißbarth, Ruprecht Kuner, Holger Sültmann

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort

    PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort by Tamara L. Lotan, Asmus Heumann, Sebastian Dwertmann Rico, Jessica Hicks, Kristen Lecksell, Christina Koop, Guido Sauter, Thorsten Schlomm, Ronald Simon

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Management of Biochemical Recurrence After Primary Treatment of Prostate Cancer: A Systematic Review of the Literature

    Management of Biochemical Recurrence After Primary Treatment of Prostate Cancer: A Systematic Review of the Literature by Sanoj Punnen, Matthew R. Cooperberg, Anthony V. D’Amico, Pierre I. Karakiewicz, Judd W. Moul, Howard I. Scher, Thorsten Schlomm, Stephen J. Freedland

    Published 2013
    Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    O-GlcNAc Transferase Integrates Metabolic Pathways to Regulate the Stability of c-MYC in Human Prostate Cancer Cells

    O-GlcNAc Transferase Integrates Metabolic Pathways to Regulate the Stability of c-MYC in Human Prostate Cancer Cells by Harri M. Itkonen, Sarah Minner, Ingrid Jenny Guldvik, Mareike Julia Sandmann, Maria Christina Tsourlakis, Viktor Berge, Aud Svindland, Thorsten Schlomm, Ian G. Mills

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    UAP1 is overexpressed in prostate cancer and is protective against inhibitors of N-linked glycosylation

    UAP1 is overexpressed in prostate cancer and is protective against inhibitors of N-linked glycosylation by Harri M. Itkonen, Nikolai Engedal, Eshrat Babaie, Morten Luhr, Ingrid Jenny Guldvik, Sarah Minner, Juliane Hohloch, Maria‐Christina Tsourlakis, Thorsten Schlomm, Ian G. Mills

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Genomic Predictors of Outcome in Prostate Cancer

    Genomic Predictors of Outcome in Prostate Cancer by Peter J. Boström, Anders Bjartell, James W.F. Catto, Scott E. Eggener, Hans Lilja, Stacy Loeb, Jack A. Schalken, Thorsten Schlomm, Matthew R. Cooperberg

    Published 2015
    Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    Currently used criteria for active surveillance in men with low‐risk prostate cancer

    Currently used criteria for active surveillance in men with low‐risk prostate cancer by Nazareno Suardi, Umberto Capitanio, Felix K.‐H. Chun, Markus Graefen, Paul Perrotte, Thorsten Schlomm, Alexander Haese, Hartwig Huland, Andreas Erbersdobler, Francesco Montorsi, Pierre I. Karakiewicz

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Marked heterogeneity of ERG expression in large primary prostate cancers

    Marked heterogeneity of ERG expression in large primary prostate cancers by Sarah Minner, Michael Gärtner, Fabian Freudenthaler, Melanie Bauer, Martina Kluth, Georg Salomon, Hans Heinzer, Markus Graefen, Carsten Bokemeyer, Ronald Simon, Guido Sauter, Thorsten Schlomm, Waldemar Wilczak

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    <i>TMPRSS2:ERG</i> fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis

    <i>TMPRSS2:ERG</i> fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis by Kari Rostad, Olaf Hellwinkel, Svein A. Haukaas, Ole J. Halvorsen, Anne M. Øyan, Alexander Haese, Lars Budäus, HEIKO ALBRECHT, Lars A. Akslen, Thorsten Schlomm, Karl-Henning Kalland

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Salvage radical prostatectomy for recurrent prostate cancer: verification of European Association of Urology guideline criteria

    Salvage radical prostatectomy for recurrent prostate cancer: verification of European Association of Urology guideline criteria by Philipp Mandel, Thomas Steuber, Sascha Ahyai, Maximilian C. Kriegmair, Jonas Schiffmann, Katharina Böehm, Hans Heinzer, Uwe Michl, Thorsten Schlomm, Alexander Haese, Hartwig Huland, Markus Graefen, Derya Tilki

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Clinical Significance of Epidermal Growth Factor Receptor Protein Overexpression and Gene Copy Number Gains in Prostate Cancer

    Clinical Significance of Epidermal Growth Factor Receptor Protein Overexpression and Gene Copy Number Gains in Prostate Cancer by Thorsten Schlomm, Patrick Kirstein, Liv Iwers, Birte Daniel, Thomas Steuber, Jochen Walz, Felix Chun, Alexander Haese, Jens Köllermann, Markus Graefen, Hartwig Huland, Guido Sauter, Ronald Simon, Andreas Erbersdobler

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Spatial expression of HER2, NECTIN4, and TROP-2 in Muscle-Invasive Bladder Cancer and metastases: Implications for pathological and clinical management

    Spatial expression of HER2, NECTIN4, and TROP-2 in Muscle-Invasive Bladder Cancer and metastases: Implications for pathological and clinical management by Gabriel Dernbach, Marie‐Lisa Eich, Mihnea P. Dragomir, Philipp Anders, Nadia Jurczok, Christian G. Stief, Philipp Jurmeister, Thorsten Schlomm, Frederick Klauschen, David Horst, Gerald Bastian Schulz, Simon Schallenberg

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation

    Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation by Ramesh Ummanni, Edgar Jost, Melanie Braig, Frithjof Lohmann, Frederike Mundt, Christine Barett, Thorsten Schlomm, Guido Sauter, Tina Senff, Carsten Bokemeyer, Holger Sültmann, Catherine Meyer-Schwesinger, Tim H. Brümmendorf, Stefan Balabanov

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    <i>CHD1</i> Is a 5q21 Tumor Suppressor Required for <i>ERG</i> Rearrangement in Prostate Cancer

    <i>CHD1</i> Is a 5q21 Tumor Suppressor Required for <i>ERG</i> Rearrangement in Prostate Cancer by Lia Burkhardt, Sarah Fuchs, Antje Krohn, Sawinee Masser, Malte Mäder, Martina Kluth, Frederik Bachmann, Hartwig Huland, Thomas Steuber, Markus Graefen, Thorsten Schlomm, Sarah Minner, Guido Sauter, Hüseyin Sirma, Ronald Simon

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Solid organ transplantation programs facing lack of empiric evidence in the COVID-19 pandemic: A By-proxy Society Recommendation Consensus approach

    Solid organ transplantation programs facing lack of empiric evidence in the COVID-19 pandemic: A By-proxy Society Recommendation Consensus approach by Paul Viktor Ritschl, Nora Nevermann, Leke Wiering, Helen Wu, Philipp Moroder, Andreas Brandl, Karl H. Hillebrandt, Frank Tacke, Frank Friedersdorff, Thorsten Schlomm, Wenzel Schöning, Robert Öllinger, Moritz Schmelzle, Johann Pratschke

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    High mitochondria content is associated with prostate cancer disease progression

    High mitochondria content is associated with prostate cancer disease progression by Katharina Grupp, Karolina Jedrzejewska, Maria Christina Tsourlakis, Christina Koop, Waldemar Wilczak, Meike Adam, Alexander Quaas, Guido Sauter, Ronald Simon, Jakob R. Izbicki, Markus Graefen, Hartwig Huland, Thorsten Schlomm, Sarah Minner, Stefan Steurer

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    βIII-Tubulin Overexpression Is an Independent Predictor of Prostate Cancer Progression Tightly Linked to ERG Fusion Status and PTEN Deletion

    βIII-Tubulin Overexpression Is an Independent Predictor of Prostate Cancer Progression Tightly Linked to ERG Fusion Status and PTEN Deletion by Maria Tsourlakis, Philipp Weigand, Katharina Grupp, Martina Kluth, Stefan Steurer, Thorsten Schlomm, Markus Graefen, Hartwig Huland, Georg Salomon, Thomas Steuber, Waldemar Wilczak, Hüseyin Sirma, Ronald Simon, Guido Sauter, Sarah Minner, Alexander Quaas

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Cytoplasmic Accumulation of Sequestosome 1 (p62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation, and Genomic Instability in Prostate Cancer

    Cytoplasmic Accumulation of Sequestosome 1 (p62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation, and Genomic Instability in Prostate Cancer by Christoph Burdelski, Viktor Reiswich, Claudia Hube‐Magg, Martina Kluth, Sarah Minner, Christina Koop, Markus Graefen, Hans Heinzer, Maria Christina Tsourlakis, Corinna Wittmer, Hartwig Huland, Ronald Simon, Thorsten Schlomm, Guido Sauter, Stefan Steurer

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    High level PSMA expression is associated with early psa recurrence in surgically treated prostate cancer

    High level PSMA expression is associated with early psa recurrence in surgically treated prostate cancer by Sarah Minner, Corinna Wittmer, Markus Graefen, Georg Salomon, Thomas Steuber, Alexander Haese, Hartwig Huland, Carsten Bokemeyer, Emre F. Yekebas, Judith Dierlamm, Stefan Balabanov, Ergin Kilic, Waldemar Wilczak, Ronald Simon, Guido Sauter, Thorsten Schlomm

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: